For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| OMS721 (Narsoplimab) | Administration of OMS721 (narsoplimab) OMS721 (narsoplimab): Intravenous loading dose followed by daily subcutaneous injections | 1 | None | 5 | 6 | 6 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| THROMBOCYTOPENIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 25 | View |
| RENAL GRAFT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| ESCHERICHIA SEPSIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| CEREBRAL HEMATOMA | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 25 | View |
| LEUKOPENIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 25 | View |
| HAEMOLYSIS | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 25 | View |
| CHRONIC ALLOGRAFT NEPHROPATHY | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 25 | View |
| KIDNEY TRANSPLANT REJECTION | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 25 | View |
| CHRONIC KIDNEY DISEASE | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 25 | View |
| ARTERIOVENOUSE FISTULA ANEURYSM | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| HEPATIC FAILURE | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA 25 | View |
| PNEUMONIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| URINARY TRACT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| SHUNT BLOOD FLOW EXCESSIVE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| PULMONARY HYPERTENSION | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 25 | View |
| PURPURA | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 25 | View |
| HYPERTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 25 | View |
| Cardiac failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 25 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| BRADYCARDIA | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 25 | View |
| HAEMOLYSIS | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 25 | View |
| IRON DEFICIENCY ANAEMIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 25 | View |
| CARDIAC FAILURE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 25 | View |
| HYPERTROPHIC CARDIOMYOPATHY | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | MedDRA 25 | View |
| ADRENAL INSUFFICIENCY | SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDRA 25 | View |
| HYPERTHYROIDISM | SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDRA 25 | View |
| ASCITES | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| DIARRHOEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| ENTEROCOLITIS | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| GASTROINTESTINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| NAUSEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| OESOPHAGEAL ULCER | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 25 | View |
| INJECTION SITE EXTRAVASATION | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25 | View |
| INJECTION SITE HAEMATOMA | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25 | View |
| INJECTION SITE PAIN | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25 | View |
| OEDEMA PERIPHERAL | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25 | View |
| PYREXIA | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25 | View |
| CHRONIC ALLOGRAFT NEPHROPATHY | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 25 | View |
| HYPERSENSITIVITY | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 25 | View |
| KIDNEY TRANSPLANT REJECTION | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 25 | View |
| ARTERIOVENOUS FISTULA SITE INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| BACTERIAL INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| CLOSTRIDIUM DIFFICILE INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| MOLLUSCUM CONTAGIOSUM | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| RENAL GRAFT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| UREAPLASMA INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| URINARY TRACT INFECTION ENTEROCOCCAL | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25 | View |
| ARTERIOVENOUS FISTULA ANEURYSUM | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| POST PROCEDURAL HAEMATOMA | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| SHUNT BLOOD FLOW EXCESSIVE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| SUBDURAL HAEMATOMA | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 25 | View |
| BLOOD CHOLESTEROL INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 25 | View |
| C-REACTIVE PROTEIN INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 25 | View |
| ELECTROCARDIOGRAM QT PROLONGED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 25 | View |
| HUMAN CHORIONIC GONADOTROPIN ABNORMAL | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 25 | View |
| TREPONEMA TEST POSITIVE | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 25 | View |
| HYPERKALAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 25 | View |
| HYPERPHOSPHATAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 25 | View |
| HYPERURICAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 25 | View |
| HYPOCALCAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 25 | View |
| ARTHRALGIA | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 25 | View |
| BACK PAIN | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 25 | View |
| PAIN IN EXTREMITY | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 25 | View |
| EPILEPSY | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 25 | View |
| HEADACHE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 25 | View |
| NEUROLOGICAL SYMPTOM | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 25 | View |
| AGRESSION | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 25 | View |
| ANXIETY | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 25 | View |
| INSOMNIA | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 25 | View |
| CHRONIC KIDNEY DISEASE | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 25 | View |
| HAEMATURIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 25 | View |
| LEUKOCYTURIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 25 | View |
| AMENORRHOEA | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 25 | View |
| ALOPECIA | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 25 | View |
| PURPURA | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 25 | View |
| HYPERTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 25 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 25 | View |
| Dysmenorrhoea | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 25 | View |